• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Multiple Myeloma (Kahler's Disease) Global Clinical Trials Review, H2, 2012 Product Image

Multiple Myeloma (Kahler's Disease) Global Clinical Trials Review, H2, 2012

  • ID: 2368604
  • December 2012
  • Region: Global
  • 186 pages
  • GlobalData

Multiple Myeloma (Kahler’s Disease) Global Clinical Trials Review, H2, 2012

Summary

Our clinical trial report, “Multiple Myeloma (Kahler’s Disease) Global Clinical Trials Review, H2, 2012" provides data on the Multiple Myeloma (Kahler’s Disease) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Multiple Myeloma (Kahler’s Disease). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Multiple Myeloma (Kahler’s Disease). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Our team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials READ MORE >

List of Tables
List of Figures
Introduction
Multiple Myeloma (Kahler’s Disease)
Report Guidance
Clinical Trials by Region
Clinical Trials by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Five Countries Contributing to Clinical Trials in Middle East and Africa
Top Five Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by BRIC Nations
Clinical Trials by G7 Nations
Clinical Trials in G7 Nations by Trial Status
Clinical Trials by E7 Nations
Clinical Trials in E7 Nations by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Unaccomplished Trials of Multiple Myeloma (Kahler’s Disease)
Subjects Recruited Over a Period of Time
Prominent Sponsors
Top Companies Participating in Multiple Myeloma (Kahler’s Disease) Therapeutics Clinical Trials
Prominent Drug Comparison
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
Celgene Corporation
Clinical Trial Overview of Celgene Corporation
Novartis AG
Clinical Trial Overview of Novartis AG
Millennium Pharmaceuticals, Inc.
Clinical Trial Overview of Millennium Pharmaceuticals, Inc.
Johnson & Johnson
Clinical Trial Overview of Johnson & Johnson
Onyx Pharmaceuticals, Inc.
Clinical Trial Overview of Onyx Pharmaceuticals, Inc.
Bristol-Myers Squibb Company
Clinical Trial Overview of Bristol-Myers Squibb Company
Merck & Co., Inc.
Clinical Trial Overview of Merck & Co., Inc.
Genzyme Corporation
Clinical Trial Overview of Genzyme Corporation
GlaxoSmithKline plc
Clinical Trial Overview of GlaxoSmithKline plc
Amgen Inc.
Clinical Trial Overview of Amgen Inc.
Pfizer Inc.
Clinical Trial Overview of Pfizer Inc.
Cephalon, Inc.
Clinical Trial Overview of Cephalon, Inc.
Janssen-Cilag Gmbh
Clinical Trial Overview of Janssen-Cilag Gmbh
Janssen Research & Development LLC
Clinical Trial Overview of Janssen Research & Development LLC
Abbott Laboratories
Clinical Trial Overview of Abbott Laboratories
Sanofi
Clinical Trial Overview of Sanofi
Genentech, Inc.
Clinical Trial Overview of Genentech, Inc.
Pharmacyclics, Inc.
Clinical Trial Overview of Pharmacyclics, Inc.
Innate Pharma SA
Clinical Trial Overview of Innate Pharma SA
Janssen Korea Ltd.
Clinical Trial Overview of Janssen Korea Ltd.
Clinical Trial Overview of Top Universities / Institutes / Hospitals
The University of Texas M. D. Anderson Cancer Center
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center
Fred Hutchinson Cancer Research Center
Clinical Trial Overview of Fred Hutchinson Cancer Research Center
University of Arkansas
Clinical Trial Overview of University of Arkansas
Mayo Clinic
Clinical Trial Overview of Mayo Clinic
Memorial Sloan Kettering Cancer Center
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center
Sidney Kimmel Comprehensive Cancer Center
Clinical Trial Overview of Sidney Kimmel Comprehensive Cancer Center
H. Lee Moffitt Cancer Center & Research Institute
Clinical Trial Overview of H. Lee Moffitt Cancer Center & Research Institute
Barbara Ann Karmanos Cancer Institute
Clinical Trial Overview of Barbara Ann Karmanos Cancer Institute
Dana-Farber Cancer Institute
Clinical Trial Overview of Dana-Farber Cancer Institute
Masonic Cancer Center
Clinical Trial Overview of Masonic Cancer Center
Massachusetts General Hospital
Clinical Trial Overview of Massachusetts General Hospital
Case Comprehensive Cancer Center
Clinical Trial Overview of Case Comprehensive Cancer Center
City of Hope National Medical Center
Clinical Trial Overview of City of Hope National Medical Center
University of California, San Francisco
Clinical Trial Overview of University of California, San Francisco
Washington University School of Medicine
Clinical Trial Overview of Washington University School of Medicine
Duke University
Clinical Trial Overview of Duke University
University of Leeds
Clinical Trial Overview of University of Leeds
Stanford University
Clinical Trial Overview of Stanford University
Roswell Park Cancer Institute
Clinical Trial Overview of Roswell Park Cancer Institute
University of Michigan Comprehensive Cancer Center
Clinical Trial Overview of University of Michigan Comprehensive Cancer Center
Five Key Clinical Profiles
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About Us
Contact Us
Disclaimer
Source

List of Tables
Multiple Myeloma (Kahler’s Disease) Therapeutics Market, Global, Clinical Trials by Zone, 2012-
Multiple Myeloma (Kahler’s Disease) Therapeutics Market, Global, Clinical Trials by Top Countries, 2012-
Multiple Myeloma (Kahler’s Disease) Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012-
Multiple Myeloma (Kahler’s Disease) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012-
Multiple Myeloma (Kahler’s Disease) Therapeutics Clinical Trials, Europe, Top Five Countries, 2012-
Multiple Myeloma (Kahler’s Disease) Therapeutics Clinical Trials, North America, Top Countries, 2012-
Multiple Myeloma (Kahler’s Disease) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2012-
Multiple Myeloma (Kahler’s Disease) Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2012-
Multiple Myeloma (Kahler’s Disease) Therapeutics Clinical Trials, BRIC Countries, 2012-
Multiple Myeloma (Kahler’s Disease) Therapeutics Clinical Trials, G7 Countries, 2012-
Multiple Myeloma (Kahler’s Disease) Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012-
Multiple Myeloma (Kahler’s Disease) Therapeutics Clinical Trials, E7 Countries, 2012-
Multiple Myeloma (Kahler’s Disease) Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012-
Multiple Myeloma (Kahler’s Disease) Therapeutics Market, Global, Clinical Trials by Phase, 2012-
Multiple Myeloma (Kahler’s Disease) Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012-
Multiple Myeloma (Kahler’s Disease) Therapeutics Market, Global, Clinical Trials by Trial Status, 2012-
Multiple Myeloma (Kahler’s Disease) Therapeutics Market, Global, Suspended Clinical Trials, 2012-
Multiple Myeloma (Kahler’s Disease) Therapeutics Market, Global, Withdrawn Clinical Trials, 2012-
Multiple Myeloma (Kahler’s Disease) Therapeutics Market, Global, Terminated Clinical Trials, 2012-
Multiple Myeloma (Kahler’s Disease) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011
Multiple Myeloma (Kahler’s Disease) Therapeutics Clinical Trials, Global, Key Sponsors, 2012-
Multiple Myeloma (Kahler’s Disease) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012-
Multiple Myeloma (Kahler’s Disease) Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012-
Multiple Myeloma (Kahler’s Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Celgene Corporation, 2012-
Multiple Myeloma (Kahler’s Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2012-
Multiple Myeloma (Kahler’s Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Millennium Pharmaceuticals, Inc., 2012-
Multiple Myeloma (Kahler’s Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2012-
Multiple Myeloma (Kahler’s Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Onyx Pharmaceuticals, Inc., 2012-
Multiple Myeloma (Kahler’s Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2012-
Multiple Myeloma (Kahler’s Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2012-
Multiple Myeloma (Kahler’s Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Genzyme Corporation, 2012-
Multiple Myeloma (Kahler’s Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2012-
Multiple Myeloma (Kahler’s Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2012-
Multiple Myeloma (Kahler’s Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2012-
Multiple Myeloma (Kahler’s Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Cephalon, Inc., 2012-
Multiple Myeloma (Kahler’s Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Janssen-Cilag Gmbh, 2012-
Multiple Myeloma (Kahler’s Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Janssen Research & Development LLC, 2012-
Multiple Myeloma (Kahler’s Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2012-
Multiple Myeloma (Kahler’s Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2012-
Multiple Myeloma (Kahler’s Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Genentech, Inc., 2012-
Multiple Myeloma (Kahler’s Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Pharmacyclics, Inc., 2012-
Multiple Myeloma (Kahler’s Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Innate Pharma SA, 2012-
Multiple Myeloma (Kahler’s Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Janssen Korea Ltd., 2012-
Multiple Myeloma (Kahler’s Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2012-
Multiple Myeloma (Kahler’s Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center, 2012-
Multiple Myeloma (Kahler’s Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Arkansas, 2012-
Multiple Myeloma (Kahler’s Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2012-
Multiple Myeloma (Kahler’s Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2012-
Multiple Myeloma (Kahler’s Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Sidney Kimmel Comprehensive Cancer Center, 2012-
Multiple Myeloma (Kahler’s Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by H. Lee Moffitt Cancer Center & Research Institute, 2012-
Multiple Myeloma (Kahler’s Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Barbara Ann Karmanos Cancer Institute, 2012-
Multiple Myeloma (Kahler’s Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Dana-Farber Cancer Institute, 2012-
Multiple Myeloma (Kahler’s Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Masonic Cancer Center, 2012-
Multiple Myeloma (Kahler’s Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2012-
Multiple Myeloma (Kahler’s Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Case Comprehensive Cancer Center, 2012-
Multiple Myeloma (Kahler’s Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by City of Hope National Medical Center, 2012-
Multiple Myeloma (Kahler’s Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2012-
Multiple Myeloma (Kahler’s Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Washington University School of Medicine, 2012-
Multiple Myeloma (Kahler’s Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2012-
Multiple Myeloma (Kahler’s Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Leeds, 2012-
Multiple Myeloma (Kahler’s Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2012-
Multiple Myeloma (Kahler’s Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Roswell Park Cancer Institute, 2012-
Multiple Myeloma (Kahler’s Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Michigan Comprehensive Cancer Center, 2012-

List of Figures
Multiple Myeloma (Kahler’s Disease) Therapeutics Market, Global, Clinical Trials by Zone (%), 2012-
Multiple Myeloma (Kahler’s Disease) Therapeutics Market, Global, Clinical Trials by Top Countries, 2012-
Multiple Myeloma (Kahler’s Disease) Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012-
Multiple Myeloma (Kahler’s Disease) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012-
Multiple Myeloma (Kahler’s Disease) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012-
Multiple Myeloma (Kahler’s Disease) Therapeutics Clinical Trials, North America, Top Countries (%), 2012-
Multiple Myeloma (Kahler’s Disease) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2012-
Multiple Myeloma (Kahler’s Disease) Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2012-
Multiple Myeloma (Kahler’s Disease) Therapeutics Clinical Trials, BRIC Countries (%), 2012-
Multiple Myeloma (Kahler’s Disease) Therapeutics Clinical Trials, G7 Countries (%), 2012-
Multiple Myeloma (Kahler’s Disease) Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012-
Multiple Myeloma (Kahler’s Disease) Therapeutics Clinical Trials, E7 Countries (%), 2012-
Multiple Myeloma (Kahler’s Disease) Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012-
Multiple Myeloma (Kahler’s Disease) Therapeutics Market, Global, Clinical Trials by Phase (%), 2012-
Multiple Myeloma (Kahler’s Disease) Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012-
Multiple Myeloma (Kahler’s Disease) Therapeutics Market, Global, Clinical Trials by Trial Status, 2012-
Multiple Myeloma (Kahler’s Disease) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011
Multiple Myeloma (Kahler’s Disease) Therapeutics Clinical Trials, Global, Key Sponsors, 2012-
Multiple Myeloma (Kahler’s Disease) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012-
Multiple Myeloma (Kahler’s Disease) Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012-
GlobalData Methodology

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos